Skip to main content

GSK plc 6-K, filed Oct 28, 2026

GSK plc (GSK)

6-K 2026-10-28 For: 2026-10-28
View Original
Added on October 28, 2026

About this 6-K

GSK plc filed this 6-K on October 28, 2026.

GSK reported Q3 sales of £8.9 billion, up 5% at CER, with core operating profit up 5%. It reaffirmed 2026 guidance for turnover growth of 3% to 5% and core operating profit growth of 7% to 9%. AI summary